|Phospho-CYLD (Ser418) Antibody 4500||20 µl||
|STAMBP Antibody 5245||20 µl||
|A20/TNFAIP3 (D13H3) Rabbit mAb 5630||20 µl||
||H M R Mk||82||Rabbit IgG|
|UCHL1 (D3T2E) XP® Rabbit mAb 13179||20 µl||
||H M R Mk||27||Rabbit IgG|
|HAUSP (D17C6) XP® Rabbit mAb 4833||20 µl||
||H M R Mk||135, 140||Rabbit IgG|
|USP9X Antibody 5751||20 µl||
||H M R Mk Dg||270||Rabbit|
|CYLD (D1A10) Rabbit mAb 8462||20 µl||
||H M R Mk||108||Rabbit IgG|
|UCHL3 (D25E6) Rabbit mAb 8141||20 µl||
||H M R||27||Rabbit IgG|
|USP10 (D7A5) Rabbit mAb 8501||20 µl||
||H M R Mk||110||Rabbit IgG|
|Anti-rabbit IgG, HRP-linked Antibody 7074||100 µl||
Phospho-CYLD (Ser418) Antibody is produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser418 of human CYLD protein. The remaining polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly194 of human STAMBP protein or Phe2130 of human USP9X protein. Polyclonal antibodies are purified by protein A and peptide affinity chromatography. Monoclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Lys37 of human CYLD protein, the amino terminus of human UCHL3 protein, the amino terminus of human USP10 protein, or to the carboxy terminus of human HAUSP protein, or the carboxy terminus of human UCHL1, or a recombinant protein specific to the amino terminus of human A20/TNFAIP3 protein. A20/TNFAIP3 (D13H3) Rabbit mAb was prepared in collaboration with Dr. Marc Schmidt-Supprian, Max Planck Institute of Biochemistry.
Explore pathways + proteins related to this product.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.